California lawmakers are weighing a bill that would cut off most drugmaker payments to physicians, including speaking fees for that staple of pharma marketing…

Novo Nordisk has moved to settle a whistleblower lawsuit alleging the company ran a “white-coat marketing scheme” to pump up sales of NovoLog, Victoza and…

The FDA is ordering major label changes on pain meds codeine and tramadol that will affect dozens of companies.

Kim Kardashian is back on social media plugging for pharma. This time, the FDA might like her Instagram post better, but Instagram followers weren't so…

Pharma has come a long way on patient centricity. Regulators, though? Not so much, Treato's CEO says.

While some analysts aren’t thrilled by Allergan's phase 2 data for Botox in depression, the company sees enough promise to move the therapy into a wide…

Mylan faces a class action lawsuit over its pricing of allergy shot EpiPen—the first suit alleging the company violated the federal RICO Act.

Big Pharma figures the Amgen vs. Sanofi patent decision, when it comes, could upturn their pipeline drugs and development choices, so they're weighing in…

Regulatory